Clinical trials
Phase 1 Carcinoma, Hepatocellular trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 5 |
| Exelixis | 2 |
| Incyte Corporation | 2 |
| Novartis Pharmaceuticals | 2 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Bayer | 1 |
| Blueprint Medicines Corporation | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Clinica Universidad de Navarra, Universidad de Navarra | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 28 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Neoplasms | 9 |
| Triple Negative Breast Neoplasms | 9 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Stomach Neoplasms | 8 |
| Carcinoma, Renal Cell | 7 |
| Colorectal Neoplasms | 7 |
| Carcinoma, Merkel Cell | 5 |
| Melanoma | 5 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.